Supernus Pharmaceuticals Inc SUPN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
30.08UNCH (UNCH)
Volume
12,238
Close
30.08quote price arrow down-0.02 (-0.07%)
Volume
371,492
52 week range
21.99 - 38.09
Loading...
  • Open30.15
  • Day High30.69
  • Day Low29.99
  • Prev Close30.10
  • 52 Week High38.09
  • 52 Week High Date05/03/23
  • 52 Week Low21.99
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap1.646B
  • Shares Out54.73M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • YTD % Change3.94

KEY STATS

  • Open30.15
  • Day High30.69
  • Day Low29.99
  • Prev Close30.10
  • 52 Week High38.09
  • 52 Week High Date05/03/23
  • 52 Week Low21.99
  • 52 Week Low Date10/27/23
  • Market Cap1.646B
  • Shares Out54.73M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • YTD % Change3.94

RATIOS/PROFITABILITY

  • EPS (TTM)-0.02
  • P/E (TTM)-1,978.95
  • Fwd P/E (NTM)18.36
  • EBITDA (TTM)99.827M
  • ROE (TTM)0.15%
  • Revenue (TTM)607.521M
  • Gross Margin (TTM)86.21%
  • Net Margin (TTM)0.22%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/08/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Supernus Pharmaceuticals Inc

 

Profile

MORE
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson’s Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and...
Charles Newhall III
Independent Chairman of the Board
Jack Khattar
President, Chief Executive Officer, Secretary, Director
Timothy Dec CPA
Chief Financial Officer, Senior Vice President
Address
9715 Key West Avenue
Rockville, MD
20850
United States

Top Peers

SYMBOLLASTCHG%CHG
HRMY
Harmony Biosciences Holdings Inc
30.27-0.64-2.07%
AMPH
Amphastar Pharmaceuticals Inc
42.08+0.83+2.01%
COLL
Collegium Pharmaceutical Inc
37.78+0.85+2.30%
PCRX
Pacira Biosciences Inc
26.95+0.70+2.67%
ANIP
ANI Pharmaceuticals Inc
66.52+0.52+0.79%